This is a routine initial ownership filing by a director/10% owner. No trading signal. Monitor for future Form 4 filings for any open-market purchases or sales by Gordon or OrbiMed affiliates.
Price Chart
Executive Summary
Carl L. Gordon, a director and OrbiMed affiliate, filed a Form 3 initial statement of beneficial ownership with Electra Therapeutics, Inc. (ETRA), reporting beneficial ownership of common stock via convertible preferred shares and a director stock option. This is a routine filing triggered by Gordon's insider status and does not convey new material information about the company's operations or financial condition.
Key Facts
- Carl L. Gordon filed a Form 3 initial statement of beneficial ownership on September 18, 2026.
- Gordon reports beneficial ownership of 2,002,310 shares of common stock via Series A Convertible Preferred Stock held by OrbiMed Private Investments VII, LP.
- Gordon reports beneficial ownership of 1,087,934 shares of common stock via Series B Convertible Preferred Stock held by OrbiMed Genesis Master Fund, L.P.
- Gordon reports beneficial ownership of 758,279 and 1,703,314 shares of common stock via Series C Convertible Preferred Stock held by OrbiMed entities.
- Gordon also holds a Director Stock Option (right to buy) for 22,632 shares of common stock, vesting on the earlier of September 17, 2027 or the next annual meeting.
- The preferred shares automatically convert into common stock 1:1 upon the closing of the Issuer's initial public offering.
Financial Impact
No financial impact; the filing reports existing beneficial ownership and a director option grant, not a transaction or change in financial condition.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001282930-26-000012 |
| Document: 0001282930-26-000012-index-headers.html | 0001282930-26-000012 |
| Document: 0001282930-26-000012-index.html | 0001282930-26-000012 |
| Document: 0001282930-26-000012.txt | 0001282930-26-000012 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 28, 2026 27d ago | SC 13G | $11.35 $11.25 | ▼ −0.88% | ▼ −0.68% | $8.71 (−23.26%) |
Sep 28, 2026 27d ago | SC 13G | $11.35 $11.25 | ▼ −0.88% | ▼ −0.68% | $8.71 (−23.26%) |
Sep 25, 2026 4w ago | SC 13D | $11.32 $11.35 | ▲ +0.27% | ▲ +0.45% | $8.71 (−23.06%) |
Sep 23, 2026 4w ago | Insider Cluster | $11.82 $11.55 | ▼ −2.28% | ▼ −2.83% | $8.71 (−26.31%) |
Sep 21, 2026 4w ago | 3 | $13.62 $12.67 | ▼ −6.97% | ▼ −6.25% | $8.71 (−36.05%) |
Sep 18, 2026 5w ago | 424B4 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.71 (−37.43%) |
Sep 18, 2026 5w ago | 3 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.71 (−37.43%) |
Sep 18, 2026 5w ago | 3 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.71 (−37.43%) |
Sep 18, 2026 5w ago | 3 | $13.92 $13.62 | ▼ −2.16% | ▼ −2.14% | $8.71 (−37.43%) |
Sep 18, 2026 5w ago | EFFECT | $13.25 $13.92 | ▲ +5.06% | ▲ +3.51% | $8.71 (−34.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers